MoneyWorks4Me

Astec Lifesciences informs about outcome of board meeting

29 Oct 2022 Evaluate
Astec Lifesciences has informed that the Board of Directors of the Company, at its Meeting held on Friday, 28th October, 2022, has approved the Unaudited Financial Results (both Standalone and Consolidated) as per Indian Accounting Standards (IND AS) for the Quarter and Half Year ended 30th September, 2022. It enclosed a copy of the Press Release and the same is being placed on the website of the Company, www.astecls.com 

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
UPL 533.50
PI Industries 2188.80
Bayer CropScience 3640.30
Sharda Cropchem 725.05
Sumitomo Chem. India 404.75
View more..